ABSTRACT
INTRODUCTION
Acute coronary syndromes (ACS) represent a severity spectrum of coronary artery diseases ranging from suspected unstable angina through acute myocardial infarction (1) . Unstable angina has been described as a clinical syndrome between stable angina and acute myocardial infarction (2) . The Egyptian National Heart Institute (NHI) received 416975 patients with suspected cardiovascular diseases in the emergency department during the year 2005; 5308 (1.2 %) of them entered the Intensive Care Unit. Open heart surgery and percutaneous coronary interventions were carried out for 1682 (0.4 %) and 10815 (2.6 %) of these patients respectively (Information Centre of the National Heart Institute, personal communication).
Cardiovascular diseases are increased in men especially those with concomitant metabolic syndromes (diabetes mellitus, hypertension and hyperlipidemia). Early identification, treatment, and prevention of these metabolic syndromes represent a major challenge for health care professionals facing an epidemic of overweight and sedentary lifestyle (3) . The biochemical markers of myocardial injury are one of the three criteria for the diagnosis of acute myocardial infarction (4) . The diagnosis of acute myocardial infarction (AMI) and unstable angina is based on typical clinical signs, electrocardiogram (ECG) changes, and serial measurements of characteristic serum enzymes (5) . The initial marker of interest used to quantitate infarct size was total Creatine kinase (Total-CK), which evolved to CK-MB fraction (CK-MB) when practical assays for the isoenzyme became available (6) . LDH determination for the diagnosis of acute myocardial infarction should be reserved for cases in which the CK has already fallen to normal or when infarction is suspected to have occurred 2 to 4 days before admission to ICU (7) . The discovery of cardiac Troponins has herald a new age in the diagnosis and treatment or management of a broad spectrum of diseases, grouped together under the heading of acute coronary syndromes and including stable and unstable angina, and Non-ST-segment elevation myocardial infarction to ST-segment elevation infarction. Cardiac Troponins, which are selectively released by damaged myocardiocytes, have specificity that they have not only allowed an improvement in the diagnosis of acute cardiac ischemic disorders, but also enabled us to make a more reliable stratification of risk prediction of outcome (8) . Serum cardiac Troponin-I elevation was initially detected with ischemic myocardial necrosis, but subsequently it has been reported with reversible ischemic myocardial injury such as in unstable angina, reversible non-ischemic myocardial injury such as in myocarditis, cardiac contusion and chemotherapy-induced myocardial injury (9, 10, 11) . The aim of this study is to asses the best biochemical marker or markers which aid in the diagnosis of acute coronary syndromes, when the patient admitted to the hospital and at 24 hours and 48 hours after their admission.
SUBJECTS &METHODS
Thirty six subjects were included in the present study, 27 patients with ACS from the Emergency Department of the ICU of The Egyptian National Heart Institute (21 males and 6 females), in addition to 9 healthy individuals served as controls.
Blood samples were collected from these patients as soon as they admitted to the ICU, and at 24 hours and 48 hours after admission. Also, blood samples were collected from the 9 healthy subjects. Sera were separated and stored at -80 ºC until analysis. All subjects were classified into four groups: Group I: Included 9 male patients with Unstable Angina (UA) with Mean ± SE age of 58 ± 4.13 years. 
RESULTS
The current study included 27 patients with Acute Coronary Syndromes (ACS). Their characters were shown in Table (1) . The mean ages were 57 ± 2 years for patients with acute coronary syndromes and 52 ± 1.7 years for the control group. Eighteen patients were suffering from hypertension, 6 were suffering from diabetes mellitus and 9 were smokers . The effect of smoking, hypertension and diabetes within the three patients groups was tested using Chi-square method and was found to be nonsignificant. For smoking (X 2 = 3, P = 0.2231), for hypertension (X 2 = 3, P = 0.2231) and for diabetes (X 2 = 1.286, P = 0.5258)
In the present study, the serum levels of the detected cardiac markers Total-CK, CK-MB, LDH and cTnI were determined on admission to ICU, and at 24 hours and 48 hours after ICU admission and were expressed as Mean ± SE and the significance from the control group or within the groups was tested statistically as shown in Table ( 2).
It was found that the mean serum level of Total-CK for the STEMI group was significantly higher than that of the control group on admission, 24 hours and 48 hours after admission to the ICU (P < 0.05). For the NSTEMI group it was significantly higher than that of the control group, on admission and 24 hours only (P< 0.05).
Also, it was found that the mean serum levels of CK-MB for the STEMI and NSTEMI groups was significantly higher than that of the control group on admission, 24 hours and 48 hours after admission to the ICU (P < 0.01). It was also found that there was a significant difference in the mean serum levels of CK-MB between the UA group and STEMI group on admission to ICU (P < 0.05).
On the other hand, it was found that the mean serum level of LDH for the STEMI group was significantly higher than that of the control group on admission (P < 0.01), 24 hours and 48 hours after admission to the ICU (P < 0.01). For the NSTEMI group it was significantly higher than that of the control group on admission only (P < 0.01).
In addition, it was found that the mean serum level of cTnI for the STEMI and NSTEMI groups was significantly higher than that of the control group on admission, 24 hours and 48 hours after admission to the ICU (P < 0.01), while for the UA group, it was significantly higher than that of the control group on admission only (P < 0.01).
In the present study, it was shown that there was a positive significant correlation between cTnI level and Total-CK, CK-MB for all of patient groups on admission, 24 hours and 48 hours after admission to ICU. For LDH, however, the positive significant correlation was found at 24 and 48 hours after admission only (Table 3) .
Sensitivity levels for all cardiac biochemical markers were calculated and presented in table (4). On admission both cTnI and CK-MB showed the highest sensitivity (59 %) while after 24 hours of ICU admission cTnI showed the highest sensitivity (85 %) and after 48 hours of ICU admission LDH showed highest sensitivity (77 %). For all cardiac markers the percent specificity was 100 %.
Diagnostic accuracy of the cardiac biochemical markers at different reference cut-off values were tested, on admission to ICU and after 24 and 48 hours. It was observed that cTnI was the most sensitive and specific marker at 24 hours after ICU admission (Fig 1, 2 and 3) . Specificity levels for all markers were 100%. 
DISCUSSION
Coronary heart disease is the most common cause of death in both women and men in large parts of the industrialized world (17) . In the present study determination of serum levels of different cardiac enzymes was carried out for evaluation of the best laboratory marker for diagnoses of acute coronary syndrome (ACS).
Creatine kinase was the initial marker used to quantitate infarct size (6) . It was reported that serum level of Total-CK began to increase within 4 to 8 hours after the onset of AMI, reached its mean peak after 24 hours and declined to normal range within 3 to 4 days after the onset of the chest pain (18) . In the present study, the mean serum level of Total-CK of the patients was found to be elevated significantly from that of the control in STEMI group on admission to ICU of the NHI, 24 and 48 hours after admission (P<0.05) while in NSTEMI group it is elevated significantly on admission and after 24 hours only (P<0.05).
Creatine Kinase-MB Isoenzyme (CK-MB) activity was reported to be increased 2 to 3 hours after AMI, reached its peak within 4 to 8 hours, and returned to normal levels within 1 to 4 days (19) . In the present study, the mean serum CK-MB activity was found to be elevated significantly than that of the control in STEMI and NSTEMI groups on admission, 24 hours and 48 hours after ICU admission (P<0.01). It was, also, observed that the mean serum CK-MB level in STEMI group was elevated significantly than that of UA group at 48 hours after ICU admission (P<0.05).
Serum Lactate Dehydrogenase (LDH) was found to be elevated within 12 to 18 hours after the onset of AMI, peaked at 48 -72 hours and returned to normal after 6 to 10 days (20) . In the present study the mean serum level of LDH was found to be elevated significantly than that of the control in STEMI group on admission (p<0.01), 24 hours and 48 hours after admission (P<0.001), while in NSTEMI group it was elevated significantly on admission only (P<0.01).
Recently, cardiac Troponin I (cTnI) is considered to be the most preferable biomarker of acute myocardial infarction (17) , since its level in the blood remains for longer period after myocardial damage than the level of CK-MB (21) . In the present study, the mean serum level of cTnI was found to be elevated significantly in STEMI, NSTEMI groups on admission, 24 hours and 48 hours post ICU admission (P<0.01) while in UA group it was elevated significantly on admission only (P<0.01). These results are in accordance with another study which reported that the assay of cardiac-specific Troponins is a sensitive and specific means to diagnose unstable coronary artery diseases (22) . On the other hand, It was found that transient mild elevation of cTnI levels in patients is associated with an increase in major cardiovascular complications (23) . It is clear from the present results, there was a positive significant correlation between serum level of cTnI, Total-CK and CK-MB activities on admission, 24 hours and 48 hours post admission and with LDH after 24 hours and 48 hours post admission. Therefore, cTnI can be used as a marker for diagnosis of ACS and can replace the other classical markers, but it is preferred to use two markers with each other to confirm the results. It was found that two markers must be used in the diagnosis of ACS the first being the early one as myoglobin, isoform of Creatine Kinase which is very sensitive and can be detected in the first two hours after myocardial damage and the second marker is confirmatory.
Confirmation of myocardial damage can be obtained by definite markers (Troponin-I or T) which are highly specific of myocardial damage (24) . It was reported that combining Troponins with other cardiac biomarkers may offer complimentary information on the underlying pathobiology and prognosis in an individual patient (25) . Also, It was demonstrated that an integration of biomarkers (TnI and CK-MB), ECG will help to identify false-positive ACS patients and avoid inappropriate admissions to Coronary Care Unit (26) . In addition, it was reported that combination of the measurements might further help in the identification of patients who would benefit from early coronary revascularization (27) . It is obvious from the present study that patients with UA showed slightly elevated cTnI while those with myocardial infarction showed higher levels of cTnI. These results are in accordance with another study which found that higher cTnI values were associated with worse outcomes. Although low cTnI values are associated with adverse events, these did not have the same implication as higher cTnI values (28) . That finding was, also, supported by another study (29) which reported that among patients with ACS, even low-level elevations of cTnT or cTnI are associated with higher risk of death and recurrent ischemic events compared with patients with a low Troponin level.
It was reported that cTnI has low sensitivity in the early hours of ACS (30) . In the present study, both cTnI and CK-MB had highest sensitivity (59 %) on admission to ICU, while after 24 hours cTnI showed highest sensitivity (85 %) and after 48 hours LDH showed highest sensitivity (77 %). The percent specificity for all the cardiac markers was 100 %.
From all biochemical markers detected, in the present study, cTnI was the most sensitive and specific one. Such finding correlated with that of Cubrilo-Turek et al.
(5) who reported that cTnI showed best discrimination and accuracy in the assessment of ACS. Also, it was reported that measurement of cTnI in serum has replaced classical biochemical markers, such as CK-MB (31) . From the result of the present study it could be concluded that cardiac Troponin I is the most preferred biochemical marker for diagnosis of ACS because of its high specificity and sensitivity. Also, it was a better marker for detection of ACS than Total-CK and its MB-Isoenzyme and Total LDH for all groups (STEMI, NSTEMI and UA). For STEMI group, it was found that persistent increase in cTnI after 48 hours of admission to ICU indicated bad prognosis and aggravation of the disease. Total LDH could not be used in early detection of ACS because it achieved highest sensitivity only after 48 hours after admission of the patients to ICU, it is reserved only for the late detection when needed. 
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